{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:53:06Z","timestamp":1790247186797,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.canrad.2021.08.005","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T19:34:50Z","timestamp":1640201690000},"page":"137-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Radiotherapy of benign intracranial tumours"],"prefix":"10.1016","volume":"26","author":[{"given":"G.","family":"Dissaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Josset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Thillays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Bourbonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Pradier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Biau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2021.08.005_bib0350","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2020.11.014","article-title":"ESTRO ACROP guideline for target volume delineation of skull base tumors","volume":"156","author":"Combs","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0355","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.canrad.2013.07.136","article-title":"[Radiotherapy for brain tumors: which margins should we apply?]","volume":"17","author":"Martin","year":"2013","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.005_bib0360","first-page":"1","article-title":"Report 91. Prescribing, recording and reporting of stereotactic treatments with samll photon beams","volume":"14","author":"Anon.","year":"2014","journal-title":"J ICRU"},{"key":"10.1016\/j.canrad.2021.08.005_bib0365","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.005_bib0370","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semradonc.2008.04.001","article-title":"An overview of hypofractionation and introduction to this issue of seminars in Radiat Oncol","volume":"18","author":"Timmerman","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0375","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.canrad.2010.03.008","article-title":"[Normal tissue tolerance to external beam radiation therapy: eye structures]","volume":"14","author":"Marchand","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.005_bib0380","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.canrad.2010.02.005","article-title":"[Normal tissue tolerance to external beam radiation therapy: brain and hypophysis]","volume":"14","author":"Haberer","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.005_bib0385","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.canrad.2016.07.032","article-title":"[Delineation of organs at risk and dose constraints]","volume":"20Suppl","author":"No\u00ebl","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.005_bib0390","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.canrad.2011.07.249","article-title":"[Stereotactic radiotherapy for intracranial meningioma]","volume":"16 Suppl","author":"Delannes","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.005_bib0395","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0400","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s13063-015-1040-3","article-title":"The ROAM\/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial","volume":"16","author":"Jenkinson","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.canrad.2021.08.005_bib0405","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.radonc.2018.08.018","article-title":"Complications after stereotactic radiosurgery for brain metastases: Incidences, correlating factors, treatments and outcomes","volume":"129","author":"Aiyama","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0410","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3171\/2016.11.JNS161170","article-title":"Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539","volume":"129","author":"Rogers","year":"2018","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2021.08.005_bib0415","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3171\/2012.7.JNS111439","article-title":"Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis","volume":"117","author":"Stessin","year":"2012","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2021.08.005_bib0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw320","article-title":"Durable control of metastatic AKT1-mutant WHO grade 1 meningothelial meningioma by the AKT inhibitor, AZD5363","volume":"109","author":"Weller","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2021.08.005_bib0425","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv377","article-title":"TERT promoter mutations and risk of recurrence in meningioma","volume":"108","author":"Sahm","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2021.08.005_bib0430","doi-asserted-by":"crossref","first-page":"18500","DOI":"10.1038\/s41598-020-75559-8","article-title":"Treatment of intracranial meningioma with single-session and fractionated radiosurgery: a propensity score matching study","volume":"10","author":"Huang","year":"2020","journal-title":"Scientific reports"},{"key":"10.1016\/j.canrad.2021.08.005_bib0435","doi-asserted-by":"crossref","first-page":"13666","DOI":"10.1038\/s41598-018-32124-8","article-title":"Hypofractionated stereotactic radiotherapy for patients with intracranial meningiomas: impact of radiotherapy regimen on local control","volume":"8","author":"Meniai-Merzouki","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.canrad.2021.08.005_bib0440","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","article-title":"EANO guidelines for the diagnosis and treatment of meningiomas","volume":"17","author":"Goldbrunner","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0445","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.radonc.2018.06.018","article-title":"Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042)","volume":"128","author":"Weber","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0450","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clon.2013.10.001","article-title":"Controversies in radiotherapy for meningioma","volume":"26","author":"Maclean","year":"2014","journal-title":"Clin Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0455","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/neuonc\/nou284","article-title":"The biology of radiosurgery and its clinical applications for brain tumors","volume":"17","author":"Kondziolka","year":"2015","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.canrad.2021.08.005_bib0460","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.canrad.2012.07.179","article-title":"[Stereotactic radiotherapy of intracranial benign tumors]","volume":"16","author":"No\u00ebl","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.005_bib0465","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.radonc.2012.10.013","article-title":"Fractionated stereotactic radiotherapy for acoustic neuromas: a prospective monocenter study of about 158 cases","volume":"106","author":"Litre","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0470","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3171\/jns.1998.88.3.0506","article-title":"Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas","volume":"88","author":"Koos","year":"1998","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2021.08.005_bib0475","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/2012.6.FOCUS12192","article-title":"The newly diagnosed vestibular schwannoma: radiosurgery, resection, or observation?","volume":"33","author":"Kondziolka","year":"2012","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.canrad.2021.08.005_bib0480","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3171\/jns.2002.97.5.1091","article-title":"Functional outcome after gamma knife surgery or microsurgery for vestibular schwannomas","volume":"97","author":"R\u00e9gis","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2021.08.005_bib0485","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1227\/01.NEU.0000340684.60443.55","article-title":"Vestibular schwannoma: surgery or gamma knife radiosurgery? A prospective, nonrandomized study","volume":"64","author":"Myrseth","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canrad.2021.08.005_bib0490","first-page":"77","article-title":"Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery","volume":"59","author":"Pollock","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canrad.2021.08.005_bib0495","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0360-3016(01)01559-0","article-title":"Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution","volume":"50","author":"Andrews","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.005_bib0500","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.1016\/j.ijrobp.2011.04.066","article-title":"Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience","volume":"81","author":"Collen","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.005_bib0505","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0360-3016(03)00444-9","article-title":"Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study","volume":"56","author":"Meijer","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.005_bib0510","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.radonc.2015.01.011","article-title":"Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas - pooled results from 3 large German centers","volume":"114","author":"Combs","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0515","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.ijrobp.2010.04.057","article-title":"Stereotactic fractionated radiotherapy and linac radiosurgery in the treatment of vestibular schwannoma-report about both stereotactic methods from a single institution","volume":"80","author":"Kopp","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.005_bib0520","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11060-013-1282-4","article-title":"Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery","volume":"116","author":"Anderson","year":"2014","journal-title":"J Neuro-Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0525","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3171\/2009.12.JNS091339","article-title":"Long-term outcomes of Gamma Knife radiosurgery in patients with vestibular schwannomas","volume":"114","author":"Murphy","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2021.08.005_bib0530","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.canrad.2012.01.006","article-title":"[Role of radiosurgery and stereotactic radiotherapy in the management of vestibular schwannomas]","volume":"16Suppl","author":"R\u00e9gis","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.005_bib0535","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ijrobp.2010.10.010","article-title":"Radiotherapy for vestibular schwannomas: a critical review","volume":"79","author":"Murphy","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.005_bib0540","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijrobp.2004.02.019","article-title":"Acoustic neuroma radiosurgery with marginal tumor doses of 12 to 13Gy","volume":"60","author":"Flickinger","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.005_bib0545","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/neuonc\/noz153","article-title":"EANO guideline on the diagnosis and treatment of vestibular schwannoma","volume":"22","author":"Goldbrunner","year":"2020","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.canrad.2021.08.005_bib0550","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jjco\/hyt082","article-title":"Hypofractionated stereotactic radiation therapy in three to five fractions for vestibular schwannoma","volume":"43","author":"Morimoto","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0555","first-page":"S90","article-title":"[Pituitary adenomas: multimodal management and modern irradiation techniques]","volume":"16 Suppl","author":"Chand-Fouch\u00e9 M\u00c8","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.005_bib0560","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fendo.2015.00097","article-title":"Progress in the diagnosis and classification of pituitary adenomas","volume":"6","author":"Syro","year":"2015","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0565","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ando.2015.04.003","article-title":"Post-surgical management of non-functioning pituitary adenoma","volume":"76","author":"Cortet-Rudelli","year":"2015","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0570","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11060-013-1262-8","article-title":"Treatment paradigms for pituitary adenomas: defining the roles of radiosurgery and radiation therapy","volume":"117","author":"Ding","year":"2014","journal-title":"J Neuro-oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0575","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13014-016-0710-y","article-title":"Target delineation and optimal radiosurgical dose for pituitary tumors","volume":"11","author":"Minniti","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0580","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/neuonc\/nor055","article-title":"Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity","volume":"13","author":"Iwata","year":"2011","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.canrad.2021.08.005_bib0585","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1278-3218(01)00091-9","article-title":"[Gross tumor volume (GTV) and clinical target volume (CTV) in radiotherapy of benign skull base tumors]","volume":"5","author":"Maire","year":"2001","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.005_bib0590","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11060-012-0806-7","article-title":"The superiority of conservative resection and adjuvant radiation for craniopharyngiomas","volume":"108","author":"Schoenfeld","year":"2012","journal-title":"J Neuro-Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0595","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ijrobp.2014.01.019","article-title":"Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience","volume":"88","author":"Lo","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.005_bib0600","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/er.2013-1115","article-title":"Craniopharyngioma","volume":"35","author":"Muller","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.canrad.2021.08.005_bib0605","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10143-009-0186-4","article-title":"The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma","volume":"32","author":"Minniti","year":"2009","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.canrad.2021.08.005_bib0610","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.radonc.2014.11.035","article-title":"Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma","volume":"114","author":"Greenfield","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0615","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11102-018-0903-5","article-title":"Single fraction and multisession Gamma Knife radiosurgery for craniopharyngioma","volume":"21","author":"Losa","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.canrad.2021.08.005_bib0620","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1748-717X-9-203","article-title":"Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects","volume":"9","author":"Harrabi","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0625","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11060-011-0693-3","article-title":"Single and hypofractionated stereotactic radiotherapy with CyberKnife for craniopharyngioma","volume":"106","author":"Iwata","year":"2012","journal-title":"J Neuro-Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0630","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.3171\/2016.9.FOCUS16298","article-title":"A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications","volume":"41","author":"Lamiman","year":"2016","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.canrad.2021.08.005_bib0635","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00005537-199901000-00007","article-title":"Malignant glomus tumors","volume":"109","author":"Manolidis","year":"1999","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2021.08.005_bib0640","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2008-2504","article-title":"The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas","volume":"94","author":"Burnichon","year":"2009","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.canrad.2021.08.005_bib0645","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cncr.10252","article-title":"National Cancer Data Base report on malignant paragangliomas of the head and neck","volume":"94","author":"Lee","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2021.08.005_bib0650","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijrobp.2014.02.010","article-title":"Treatment of head and neck paragangliomas with external beam radiation therapy","volume":"89","author":"Dupin","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.005_bib0655","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0360-3016(89)90541-5","article-title":"Twenty year experience with radiation therapy for temporal bone chemodectomas","volume":"17","author":"Pryzant","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.005_bib0660","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.radonc.2014.06.002","article-title":"The role of radiation therapy in the management of head and neck paragangliomas: impact of quality of life versus treatment response","volume":"111","author":"Galland-Girodet","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0665","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/0194599820915490","article-title":"British Skull Base Society clinical consensus document on management of head and neck paragangliomas","volume":"163","author":"Lloyd","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.canrad.2021.08.005_bib0670","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.clon.2010.02.006","article-title":"Excellent local control of paraganglioma in the head and neck with fractionated radiotherapy","volume":"22","author":"Lightowlers","year":"2010","journal-title":"Clin Oncol"},{"key":"10.1016\/j.canrad.2021.08.005_bib0675","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/hed.2880120405","article-title":"Radiation or surgery for chemodectoma of the temporal bone: a review of local control and complications","volume":"12","author":"Springate","year":"1990","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2021.08.005_bib0680","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2009.9.FOCUS09195","article-title":"Radiosurgery for glomus jugulare: history and recent progress","volume":"27","author":"Guss","year":"2009","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.canrad.2021.08.005_bib0685","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/foc.2004.17.2.4","article-title":"Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors","volume":"17","author":"Gottfried","year":"2004","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.canrad.2021.08.005_bib0690","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.amjoto.2015.06.004","article-title":"External-beam radiation therapy for malignant paraganglioma of the head and neck","volume":"36","author":"Gilbo","year":"2015","journal-title":"Am J Otolaryngol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821001943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821001943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:36:32Z","timestamp":1761136592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321821001943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":69,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1278321821001943"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2021.08.005","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy of benign intracranial tumours","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2021.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}